DataMeds AI enters IP license agreement with Reboot Health AI, issues 666,667 shares

DataMeds AI entered an IP license agreement with Reboot Health AI on Oct 13, 2026, under which Reboot grants DataMeds AI an exclusive license to its patents and health AI platform in the U.S. Reboot will receive a portion of DataMeds AI's adjusted gross revenue, and DataMeds AI will issue Reboot 666,667 shares as the IP license stock component.

Detected & updated continuously · Source: Nebula